HopeStage
Back to all studies
CompletedNCT01184235

Multidimensional Measurement of Psychopharmacological Treatment Response

It focuses on ADHD and currently lists study information in the United States.

ADHD, Autism spectrum, ...ObservationalOver 6 Months
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 6 months.

Listed locations
Fargo, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateAugust 2010
Recruitment status
Completed
Enrollment listed in the registry
44
Sponsor
Child Psychopharmacology Institute
Sponsor type
Research institute
Study type
Observational
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
Over 6 Months
Official registry ID
NCT01184235
Official title
Actigraphic, Observational, Psychometric and Biological Measurement of Psychopharmacological Treatment Response

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Fargo

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Child Psychopharmacology Institute, a research institute.

Who was this study for?

Listed age limits: from 6 months.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me